Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

pomalidomide MeSH Supplementary Concept Data 2025


MeSH Supplementary
pomalidomide
Unique ID
C467566
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C467566
Entry Term(s)
CC 4047
CC-4047
CC4047
Imnovid
Pomalyst
actimid
Pharm Action
Immunologic Factors
Angiogenesis Inhibitors
Registry Numbers
D2UX06XLB5
Heading Mapped to
Thalidomide / analogs & derivatives
Frequency
555
Note
an immunomodulator with antineoplastic and angiogenesis inhibitor activity
Source
Clin Exp Immunol 2002 Oct;130(1):75-84
Date of Entry
2002/11/06
Revision Date
2015/06/12
pomalidomide Preferred
actimid Narrower
CC-4047 Narrower
Pomalyst Narrower
Imnovid Narrower
page delivered in 0.005s